6190.T
Price:
$537
Market Cap:
$2.19B
PhoenixBio Co., Ltd. provides contract study services for drug discovery and development primarily in Japan. The company uses PXB-mouse, a chimeric mouse with a humanized liver for use in drug development experiments; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The chimeric mouse model with a humanized liver is used for in vivo studies in gene therapeutics, NASH/NAFLD drug development programs, anti-viral therapeutic tests, DMPK/toxicity studies, and custom transplantations. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
Industry
Biotechnology
IPO Date
2016-03-18
Stock Exchange
JPX
Ticker
6190.T
According to PhoenixBio Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -29.46%. This represents a change of 286.50% compared to the average of -7.62% of the last 4 quarters.
The mean historical ROE of PhoenixBio Co., Ltd. over the last ten years is -17.15%. The current -29.46% ROE has changed 71.76% with respect to the historical average. Over the past ten years (40 quarters), 6190.T's ROE was at its highest in in the September 2022 quarter at 20.57%. The ROE was at its lowest in in the March 2025 quarter at -21.60%.
Average
-17.15%
Median
-27.20%
Minimum
-46.85%
Maximum
32.57%
Discovering the peaks and valleys of PhoenixBio Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 115.34%
Maximum Annual ROE = 32.57%
Minimum Annual Increase = -2324.23%
Minimum Annual ROE = -46.85%
| Year | ROE | Change |
|---|---|---|
| 2025 | -32.64% | -2324.23% |
| 2024 | 1.47% | -95.50% |
| 2023 | 32.57% | -169.53% |
| 2022 | -46.85% | 115.34% |
| 2021 | -21.76% | -39.09% |
The current ROE of PhoenixBio Co., Ltd. (6190.T) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
0.47%
5-year avg
-13.44%
10-year avg
-17.15%
PhoenixBio Co., Ltd.’s ROE is greater than Welby Inc. (-95.96%), greater than Kringle Pharma, Inc. (-55.80%), greater than Trans Genic Inc. (-18.55%), greater than Ligua Inc. (-80.09%), less than Recovery International Co.,Ltd. (20.56%), less than D&M Co., Ltd. (9.46%), less than CEDAR.Co.,Ltd. (26.87%), greater than Kubota Pharmaceutical Holdings Co., Ltd. (-82.75%), less than Emergency Assistance Japan Co., Ltd. (4.14%), less than AHC Group Inc. (4.85%),
| Company | ROE | Market cap |
|---|---|---|
| -95.96% | $2.32B | |
| -55.80% | $2.68B | |
| -18.55% | $4.71B | |
| -80.09% | $1.33B | |
| 20.56% | $1.96B | |
| 9.46% | $2.33B | |
| 26.87% | $2.35B | |
| -82.75% | $3.00B | |
| 4.14% | $2.37B | |
| 4.85% | $1.85B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PhoenixBio Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PhoenixBio Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is PhoenixBio Co., Ltd.'s ROE?
How is the ROE calculated for PhoenixBio Co., Ltd. (6190.T)?
What is the highest ROE for PhoenixBio Co., Ltd. (6190.T)?
What is the 3-year average ROE for PhoenixBio Co., Ltd. (6190.T)?
What is the 5-year average ROE for PhoenixBio Co., Ltd. (6190.T)?
How does the current ROE for PhoenixBio Co., Ltd. (6190.T) compare to its historical average?